With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications.
Using both technologies, Flash Therapeutics can recover a wide range of therapeutics fields
“We have been working with Flash Therapeutics for several years now, and it always has been with great success.”
– Georges Kalouche, Lab Head & Senior Scientist at Sanofi
"Rapid, competent, very professional and helpful."
– Laurie Menger, Group Leader at Gustave Roussy
We look forward to negotiate partnerships and licensing agreements with pharmaceutical or biotechnological companies for the utilization, further development and global commercialization of the proprietary LentiFlash® delivery system.Join us
Discover our own internal product candidates and collaborative programmes
As observed with the COVID-19 pandemic, the lack of appropriate preclinical animal models is a major obstacle to the development of specific therapies. Existing transgenic mouse lines are not suffi...
Flash Therapeutics aims to accelerate its development strategy and strengthen its position as an expert in the bioproduction of high-purity, high-concentration DNA and RNA lentiviral solutions for ...